Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients Article

Raez, Luis E, Rolfo, Christian, Mahave, Mauricio et al. (2016). Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients . TRANSLATIONAL CANCER RESEARCH, 5 S1443-S1448. 10.21037/tcr.2016.12.14

International Collaboration

cited authors

  • Raez, Luis E; Rolfo, Christian; Mahave, Mauricio; Caglevic, Christian

sustainable development goals

authors

publication date

  • December 1, 2016

published in

keywords

  • 1ST-LINE TREATMENT
  • ANTI-PD-1 ANTIBODY
  • ATEZOLIZUMAB
  • DOCETAXEL
  • Life Sciences & Biomedicine
  • MULTICENTER
  • NIVOLUMAB
  • Oncology
  • PEMBROLIZUMAB
  • PHASE-II
  • SAFETY
  • SURVIVAL
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AME PUBLISHING COMPANY

start page

  • S1443

end page

  • S1448

volume

  • 5